

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of heat generation (GO:0031652) | 6.36637863 |
| 2 | regulation of fever generation (GO:0031620) | 6.33313447 |
| 3 | eosinophil chemotaxis (GO:0048245) | 6.01928594 |
| 4 | interferon-gamma production (GO:0032609) | 5.33601100 |
| 5 | regulation of memory T cell differentiation (GO:0043380) | 5.32241437 |
| 6 | eosinophil migration (GO:0072677) | 5.30434218 |
| 7 | regulation of heat generation (GO:0031650) | 5.17231814 |
| 8 | regulation of activation of Janus kinase activity (GO:0010533) | 5.06884352 |
| 9 | viral protein processing (GO:0019082) | 4.83632159 |
| 10 | positive regulation of osteoclast differentiation (GO:0045672) | 4.71123166 |
| 11 | T-helper cell differentiation (GO:0042093) | 4.67782122 |
| 12 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.67782122 |
| 13 | positive regulation of prostaglandin secretion (GO:0032308) | 4.62119889 |
| 14 | tolerance induction (GO:0002507) | 4.44331924 |
| 15 | keratan sulfate catabolic process (GO:0042340) | 4.40483897 |
| 16 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.25596560 |
| 17 | response to muramyl dipeptide (GO:0032495) | 4.21155402 |
| 18 | interleukin-1-mediated signaling pathway (GO:0070498) | 4.17469054 |
| 19 | regulation of prostaglandin secretion (GO:0032306) | 4.14401426 |
| 20 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.13184065 |
| 21 | T cell differentiation involved in immune response (GO:0002292) | 4.09120020 |
| 22 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 4.09120020 |
| 23 | alpha-beta T cell activation involved in immune response (GO:0002287) | 4.09120020 |
| 24 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.06760179 |
| 25 | endothelial cell chemotaxis (GO:0035767) | 4.00988507 |
| 26 | positive regulation of bone resorption (GO:0045780) | 3.99568315 |
| 27 | positive regulation of bone remodeling (GO:0046852) | 3.99568315 |
| 28 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.98016113 |
| 29 | negative regulation of bone resorption (GO:0045779) | 3.93842163 |
| 30 | positive regulation of p38MAPK cascade (GO:1900745) | 3.80301328 |
| 31 | kidney mesenchyme development (GO:0072074) | 3.78483300 |
| 32 | cellular response to interleukin-15 (GO:0071350) | 3.78420582 |
| 33 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.77994685 |
| 34 | induction of positive chemotaxis (GO:0050930) | 3.77537948 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.76146851 |
| 36 | positive regulation of defense response to virus by host (GO:0002230) | 3.75762453 |
| 37 | positive regulation of astrocyte differentiation (GO:0048711) | 3.71580131 |
| 38 | skin morphogenesis (GO:0043589) | 3.69871631 |
| 39 | negative regulation of inclusion body assembly (GO:0090084) | 3.67986812 |
| 40 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.67094490 |
| 41 | response to interleukin-15 (GO:0070672) | 3.65535592 |
| 42 | positive regulation of interleukin-17 production (GO:0032740) | 3.64686297 |
| 43 | NIK/NF-kappaB signaling (GO:0038061) | 3.57312007 |
| 44 | cell adhesion mediated by integrin (GO:0033627) | 3.56631069 |
| 45 | positive regulation of icosanoid secretion (GO:0032305) | 3.56196114 |
| 46 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.52868316 |
| 47 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.45942430 |
| 48 | regulation of mononuclear cell migration (GO:0071675) | 3.42250109 |
| 49 | negative regulation of bone remodeling (GO:0046851) | 3.41755256 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.41060752 |
| 51 | regulation of p38MAPK cascade (GO:1900744) | 3.37784039 |
| 52 | regulation of gamma-delta T cell activation (GO:0046643) | 3.37318726 |
| 53 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.32489331 |
| 54 | wound healing, spreading of epidermal cells (GO:0035313) | 3.29981363 |
| 55 | lung vasculature development (GO:0060426) | 3.29073893 |
| 56 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.28544905 |
| 57 | mammary gland epithelial cell proliferation (GO:0033598) | 3.27080255 |
| 58 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.26748209 |
| 59 | smooth muscle tissue development (GO:0048745) | 3.26696837 |
| 60 | lymph node development (GO:0048535) | 3.26569842 |
| 61 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.26222371 |
| 62 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 3.25087432 |
| 63 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.24662860 |
| 64 | oligosaccharide catabolic process (GO:0009313) | 3.24459594 |
| 65 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.24108196 |
| 66 | monocyte chemotaxis (GO:0002548) | 3.22452309 |
| 67 | positive regulation of extracellular matrix organization (GO:1903055) | 3.15366347 |
| 68 | entrainment of circadian clock by photoperiod (GO:0043153) | 3.12511382 |
| 69 | regulation of cell killing (GO:0031341) | 3.12017672 |
| 70 | positive regulation of myeloid leukocyte differentiation (GO:0002763) | 3.11561326 |
| 71 | angiogenesis involved in wound healing (GO:0060055) | 3.11538134 |
| 72 | embryonic process involved in female pregnancy (GO:0060136) | 3.10179145 |
| 73 | positive thymic T cell selection (GO:0045059) | 3.09137312 |
| 74 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.09022653 |
| 75 | mature B cell differentiation involved in immune response (GO:0002313) | 3.08226165 |
| 76 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.08209750 |
| 77 | alpha-beta T cell differentiation (GO:0046632) | 3.07831399 |
| 78 | positive regulation of macrophage differentiation (GO:0045651) | 3.05298425 |
| 79 | ER overload response (GO:0006983) | 3.04856218 |
| 80 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.03760299 |
| 81 | cell proliferation involved in kidney development (GO:0072111) | 3.03733729 |
| 82 | negative regulation of lipid storage (GO:0010888) | 3.02381767 |
| 83 | vitamin A metabolic process (GO:0006776) | 3.02335961 |
| 84 | negative regulation of interleukin-10 production (GO:0032693) | 3.02227572 |
| 85 | virion assembly (GO:0019068) | 3.02060376 |
| 86 | positive regulation of cell fate commitment (GO:0010455) | 3.00523337 |
| 87 | T cell activation involved in immune response (GO:0002286) | 2.99916729 |
| 88 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.99367246 |
| 89 | fibroblast migration (GO:0010761) | 2.98727586 |
| 90 | regulation of bone resorption (GO:0045124) | 2.97128815 |
| 91 | response to progesterone (GO:0032570) | 2.96721722 |
| 92 | positive regulation of vasculogenesis (GO:2001214) | 2.96274965 |
| 93 | polyamine biosynthetic process (GO:0006596) | 2.92171899 |
| 94 | alpha-beta T cell activation (GO:0046631) | 2.92039563 |
| 95 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.91314931 |
| 96 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.89339463 |
| 97 | positive regulation of fatty acid transport (GO:2000193) | 2.88562140 |
| 98 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.87978805 |
| 99 | regulation of defense response to virus by host (GO:0050691) | 2.87124412 |
| 100 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.86982055 |
| 101 | response to corticosterone (GO:0051412) | 2.86897013 |
| 102 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.86487567 |
| 103 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.86471608 |
| 104 | metanephric mesenchyme development (GO:0072075) | 2.86466582 |
| 105 | regulation of T-helper 1 type immune response (GO:0002825) | 2.85843584 |
| 106 | positive regulation of cell killing (GO:0031343) | 2.85151801 |
| 107 | extracellular matrix assembly (GO:0085029) | 2.85140883 |
| 108 | positive regulation of receptor recycling (GO:0001921) | 2.82826827 |
| 109 | negative regulation of tissue remodeling (GO:0034104) | 2.82424034 |
| 110 | endoderm formation (GO:0001706) | 2.82153916 |
| 111 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.81614975 |
| 112 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.81143630 |
| 113 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.79334549 |
| 114 | negative regulation of cell killing (GO:0031342) | 2.79334549 |
| 115 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.79017280 |
| 116 | ovulation from ovarian follicle (GO:0001542) | 2.78920332 |
| 117 | mammary gland alveolus development (GO:0060749) | 2.78877320 |
| 118 | adhesion of symbiont to host (GO:0044406) | 2.78613841 |
| 119 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.77159783 |
| 120 | virion attachment to host cell (GO:0019062) | 2.75866346 |
| 121 | adhesion of symbiont to host cell (GO:0044650) | 2.75866346 |
| 122 | positive regulation of calcium ion import (GO:0090280) | 2.74459790 |
| 123 | positive regulation of odontogenesis (GO:0042482) | 2.73881218 |
| 124 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.73782350 |
| 125 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.72863738 |
| 126 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.72863738 |
| 127 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.72743557 |
| 128 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.72699944 |
| 129 | regulation of icosanoid secretion (GO:0032303) | 2.71775662 |
| 130 | protein localization to endosome (GO:0036010) | 2.71553898 |
| 131 | negative regulation of complement activation (GO:0045916) | 2.71432466 |
| 132 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.70838710 |
| 133 | membrane raft organization (GO:0031579) | 2.70371476 |
| 134 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.70147959 |
| 135 | positive regulation of osteoblast proliferation (GO:0033690) | 2.69882004 |
| 136 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.68943380 |
| 137 | response to hyperoxia (GO:0055093) | 2.67800726 |
| 138 | response to increased oxygen levels (GO:0036296) | 2.67800726 |
| 139 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.67685240 |
| 140 | decidualization (GO:0046697) | 2.67088312 |
| 141 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.67079074 |
| 142 | negative regulation of interleukin-2 production (GO:0032703) | 2.65417610 |
| 143 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.65070480 |
| 144 | glial cell migration (GO:0008347) | 2.63288605 |
| 145 | signal peptide processing (GO:0006465) | 2.62649456 |
| 146 | osteoclast differentiation (GO:0030316) | 2.61830253 |
| 147 | extracellular fibril organization (GO:0043206) | 2.60633681 |
| 148 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.60602408 |
| 149 | endocrine hormone secretion (GO:0060986) | 2.57758948 |
| 150 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.56994090 |
| 151 | response to lipoprotein particle (GO:0055094) | 2.56356474 |
| 152 | positive regulation of metanephros development (GO:0072216) | 2.55216454 |
| 153 | regulation of collagen metabolic process (GO:0010712) | 2.52535639 |
| 154 | macroautophagy (GO:0016236) | 2.52493092 |
| 155 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.52078610 |
| 156 | positive regulation of positive chemotaxis (GO:0050927) | 2.50239274 |
| 157 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.50225659 |
| 158 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.47074845 |
| 159 | Notch signaling involved in heart development (GO:0061314) | 2.45827527 |
| 160 | COPI coating of Golgi vesicle (GO:0048205) | 2.45016787 |
| 161 | Golgi transport vesicle coating (GO:0048200) | 2.45016787 |
| 162 | cellular response to arsenic-containing substance (GO:0071243) | 2.44456857 |
| 163 | positive regulation of fat cell differentiation (GO:0045600) | 2.43868243 |
| 164 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.43216563 |
| 165 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.43024398 |
| 166 | barbed-end actin filament capping (GO:0051016) | 2.42829449 |
| 167 | fibril organization (GO:0097435) | 2.42632661 |
| 168 | wound healing, spreading of cells (GO:0044319) | 2.41886678 |
| 169 | regulation of positive chemotaxis (GO:0050926) | 2.40826953 |
| 170 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.40439581 |
| 171 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.39959930 |
| 172 | regulation of vitamin metabolic process (GO:0030656) | 2.38977936 |
| 173 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.38709311 |
| 174 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.37862107 |
| 175 | surfactant homeostasis (GO:0043129) | 2.37152854 |
| 176 | cell migration involved in heart development (GO:0060973) | 2.35484358 |
| 177 | endodermal cell differentiation (GO:0035987) | 2.35372451 |
| 178 | substrate-dependent cell migration (GO:0006929) | 2.34955285 |
| 179 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.34879500 |
| 180 | mesodermal cell differentiation (GO:0048333) | 2.34208077 |
| 181 | activation of MAPKKK activity (GO:0000185) | 2.33106909 |
| 182 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.32480208 |
| 183 | tonic smooth muscle contraction (GO:0014820) | 2.31633705 |
| 184 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.31290792 |
| 185 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.30727787 |
| 186 | mRNA transcription (GO:0009299) | 2.30619673 |
| 187 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.30168441 |
| 188 | apoptotic cell clearance (GO:0043277) | 2.29946964 |
| 189 | chemical homeostasis within a tissue (GO:0048875) | 2.29598921 |
| 190 | protein heterotrimerization (GO:0070208) | 2.29559193 |
| 191 | stress fiber assembly (GO:0043149) | 2.28475876 |
| 192 | retinal metabolic process (GO:0042574) | 2.27926302 |
| 193 | positive regulation of protein autophosphorylation (GO:0031954) | 2.27739317 |
| 194 | negative regulation of protein activation cascade (GO:2000258) | 2.27736692 |
| 195 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.27634687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.55049950 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.52126523 |
| 3 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 5.13174721 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.25148127 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.53707091 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.41165093 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.24234772 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.15116750 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.95304125 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.74832731 |
| 11 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.61364046 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.61139472 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49723638 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.48889671 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.35853104 |
| 16 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.32833298 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.20548984 |
| 18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.15007189 |
| 19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.14927365 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.12656576 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03972456 |
| 22 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.03624828 |
| 23 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.91623373 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 1.88259012 |
| 25 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.86336489 |
| 26 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.86002791 |
| 27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.85561146 |
| 28 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80501064 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.78717028 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.78567042 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.78412163 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.73454892 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72685225 |
| 34 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.71100793 |
| 35 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.71012670 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.69490192 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.65637872 |
| 38 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.65336831 |
| 39 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.65336831 |
| 40 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.64919260 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64703890 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.61842325 |
| 43 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.59207638 |
| 44 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.58663195 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57915138 |
| 46 | TP53_16413492_ChIP-PET_HCT116_Human | 1.57755632 |
| 47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.55128615 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54584087 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54206411 |
| 50 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53631810 |
| 51 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.49759392 |
| 52 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.48210797 |
| 53 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.47867631 |
| 54 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47692606 |
| 55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47223469 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44925497 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39570452 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39226649 |
| 59 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37861871 |
| 60 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.37110242 |
| 61 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36072136 |
| 62 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34293334 |
| 63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30733517 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30577674 |
| 65 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.30052893 |
| 66 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27611590 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26383451 |
| 68 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24859087 |
| 69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24741495 |
| 70 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22421861 |
| 71 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19990778 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16883651 |
| 73 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.16810293 |
| 74 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.16810293 |
| 75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16795920 |
| 76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16595386 |
| 77 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16235683 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16061725 |
| 79 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15484064 |
| 80 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15484064 |
| 81 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13304503 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11978262 |
| 83 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11228912 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10869271 |
| 85 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10596278 |
| 86 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09750954 |
| 87 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09153546 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08283496 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 1.07912757 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07729852 |
| 91 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07349657 |
| 92 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.05824335 |
| 93 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.04603534 |
| 94 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03720599 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02850729 |
| 96 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02802523 |
| 97 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02577865 |
| 98 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.00715504 |
| 99 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.00419192 |
| 100 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99883688 |
| 101 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.98647437 |
| 102 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98639753 |
| 103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98379630 |
| 104 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98296955 |
| 105 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98255291 |
| 106 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97756622 |
| 107 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96668776 |
| 108 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.96041236 |
| 109 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95045918 |
| 110 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94237229 |
| 111 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93865801 |
| 112 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93648935 |
| 113 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92832083 |
| 114 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92747553 |
| 115 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92218805 |
| 116 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91543115 |
| 117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91136808 |
| 118 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91092207 |
| 119 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89973059 |
| 120 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89732332 |
| 121 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.89295335 |
| 122 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87762631 |
| 123 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87549548 |
| 124 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87489773 |
| 125 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.87159461 |
| 126 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.87125685 |
| 127 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87110033 |
| 128 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86715250 |
| 129 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.86563386 |
| 130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.85908516 |
| 131 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.85194009 |
| 132 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.84222536 |
| 133 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83906350 |
| 134 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.83395836 |
| 135 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.81843128 |
| 136 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.81514339 |
| 137 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78735295 |
| 138 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.78645229 |
| 139 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.78380084 |
| 140 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.78077842 |
| 141 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76272324 |
| 142 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76071344 |
| 143 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.75762968 |
| 144 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.75555984 |
| 145 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.74819818 |
| 146 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.74663684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.92371867 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 3.28954693 |
| 3 | MP0000685_abnormal_immune_system | 3.26546884 |
| 4 | MP0009840_abnormal_foam_cell | 3.21230877 |
| 5 | MP0001790_abnormal_immune_system | 2.99623011 |
| 6 | MP0005387_immune_system_phenotype | 2.99623011 |
| 7 | MP0005275_abnormal_skin_tensile | 2.96974894 |
| 8 | MP0004272_abnormal_basement_membrane | 2.86383704 |
| 9 | MP0005671_abnormal_response_to | 2.78662827 |
| 10 | MP0005257_abnormal_intraocular_pressure | 2.77491408 |
| 11 | MP0003950_abnormal_plasma_membrane | 2.76922246 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.75992868 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.48306646 |
| 14 | MP0009785_altered_susceptibility_to | 2.45208455 |
| 15 | MP0001800_abnormal_humoral_immune | 2.43694921 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.43671490 |
| 17 | MP0002405_respiratory_system_inflammati | 2.41251301 |
| 18 | MP0002009_preneoplasia | 2.37597226 |
| 19 | MP0002723_abnormal_immune_serum | 2.26899761 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.24420099 |
| 21 | MP0003091_abnormal_cell_migration | 2.20873930 |
| 22 | MP0001879_abnormal_lymphatic_vessel | 2.14568258 |
| 23 | MP0004510_myositis | 2.07444807 |
| 24 | MP0001958_emphysema | 2.06946675 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.04836879 |
| 26 | MP0003011_delayed_dark_adaptation | 2.02356018 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.98099916 |
| 28 | MP0004947_skin_inflammation | 1.94896248 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.94433926 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.93296492 |
| 31 | MP0002933_joint_inflammation | 1.92939798 |
| 32 | MP0001819_abnormal_immune_cell | 1.92172172 |
| 33 | MP0008961_abnormal_basal_metabolism | 1.90041818 |
| 34 | MP0001873_stomach_inflammation | 1.89137772 |
| 35 | MP0003436_decreased_susceptibility_to | 1.84879961 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.77729388 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.76291581 |
| 38 | MP0001502_abnormal_circadian_rhythm | 1.73993541 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.67678082 |
| 40 | MP0001851_eye_inflammation | 1.66595234 |
| 41 | MP0005165_increased_susceptibility_to | 1.66133196 |
| 42 | MP0002419_abnormal_innate_immunity | 1.66119413 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.66103044 |
| 44 | MP0003303_peritoneal_inflammation | 1.63808054 |
| 45 | MP0009780_abnormal_chondrocyte_physiolo | 1.60203981 |
| 46 | MP0002006_tumorigenesis | 1.59470881 |
| 47 | MP0003866_abnormal_defecation | 1.58605196 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.57655788 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.57572585 |
| 50 | MP0002295_abnormal_pulmonary_circulatio | 1.57560033 |
| 51 | MP0004782_abnormal_surfactant_physiolog | 1.56844296 |
| 52 | MP0005595_abnormal_vascular_smooth | 1.55874673 |
| 53 | MP0000767_abnormal_smooth_muscle | 1.54047450 |
| 54 | MP0005025_abnormal_response_to | 1.53775167 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.52473784 |
| 56 | MP0003828_pulmonary_edema | 1.51997729 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.51227754 |
| 58 | MP0002398_abnormal_bone_marrow | 1.51173496 |
| 59 | MP0002896_abnormal_bone_mineralization | 1.50576260 |
| 60 | MP0000343_altered_response_to | 1.50553703 |
| 61 | MP0000249_abnormal_blood_vessel | 1.46411114 |
| 62 | MP0000716_abnormal_immune_system | 1.45598566 |
| 63 | MP0008007_abnormal_cellular_replicative | 1.44896533 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.37406608 |
| 65 | MP0004883_abnormal_blood_vessel | 1.37154115 |
| 66 | MP0003638_abnormal_response/metabolism_ | 1.36238977 |
| 67 | MP0000604_amyloidosis | 1.35063510 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.33825249 |
| 69 | MP0003075_altered_response_to | 1.32998882 |
| 70 | MP0002722_abnormal_immune_system | 1.32853034 |
| 71 | MP0001881_abnormal_mammary_gland | 1.31527416 |
| 72 | MP0009384_cardiac_valve_regurgitation | 1.30720224 |
| 73 | MP0004264_abnormal_extraembryonic_tissu | 1.29131538 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 1.28690422 |
| 75 | MP0000751_myopathy | 1.28089986 |
| 76 | MP0002060_abnormal_skin_morphology | 1.28061111 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 1.27744709 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.27095668 |
| 79 | MP0002928_abnormal_bile_duct | 1.26207470 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.25044779 |
| 81 | MP0000689_abnormal_spleen_morphology | 1.23590952 |
| 82 | MP0005503_abnormal_tendon_morphology | 1.22860455 |
| 83 | MP0010386_abnormal_urinary_bladder | 1.22161472 |
| 84 | MP0003448_altered_tumor_morphology | 1.21780476 |
| 85 | MP0003705_abnormal_hypodermis_morpholog | 1.19850441 |
| 86 | MP0004808_abnormal_hematopoietic_stem | 1.19532237 |
| 87 | MP0000750_abnormal_muscle_regeneration | 1.18035748 |
| 88 | MP0003195_calcinosis | 1.16298542 |
| 89 | MP0003329_amyloid_beta_deposits | 1.16037905 |
| 90 | MP0003943_abnormal_hepatobiliary_system | 1.15957452 |
| 91 | MP0006054_spinal_hemorrhage | 1.15143284 |
| 92 | MP0009278_abnormal_bone_marrow | 1.14068969 |
| 93 | MP0002429_abnormal_blood_cell | 1.13821758 |
| 94 | MP0006082_CNS_inflammation | 1.12129172 |
| 95 | MP0001853_heart_inflammation | 1.11974169 |
| 96 | MP0005670_abnormal_white_adipose | 1.08974304 |
| 97 | MP0002332_abnormal_exercise_endurance | 1.08972623 |
| 98 | MP0008004_abnormal_stomach_pH | 1.08669795 |
| 99 | MP0005164_abnormal_response_to | 1.08477003 |
| 100 | MP0009764_decreased_sensitivity_to | 1.07935054 |
| 101 | MP0005390_skeleton_phenotype | 1.06753509 |
| 102 | MP0005166_decreased_susceptibility_to | 1.03027663 |
| 103 | MP0003453_abnormal_keratinocyte_physiol | 1.02467716 |
| 104 | MP0005197_abnormal_uvea_morphology | 1.02357990 |
| 105 | MP0000678_abnormal_parathyroid_gland | 0.99615802 |
| 106 | MP0003795_abnormal_bone_structure | 0.99043511 |
| 107 | MP0003045_fibrosis | 0.97835965 |
| 108 | MP0000858_altered_metastatic_potential | 0.97448532 |
| 109 | MP0005464_abnormal_platelet_physiology | 0.97367348 |
| 110 | MP0002972_abnormal_cardiac_muscle | 0.97103273 |
| 111 | MP0004084_abnormal_cardiac_muscle | 0.96980693 |
| 112 | MP0000013_abnormal_adipose_tissue | 0.95633360 |
| 113 | MP0000534_abnormal_ureter_morphology | 0.95607349 |
| 114 | MP0008995_early_reproductive_senescence | 0.95343572 |
| 115 | MP0001501_abnormal_sleep_pattern | 0.94607362 |
| 116 | MP0001243_abnormal_dermal_layer | 0.91684220 |
| 117 | MP0002090_abnormal_vision | 0.90083390 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.87868654 |
| 119 | MP0010352_gastrointestinal_tract_polyps | 0.87740936 |
| 120 | MP0005620_abnormal_muscle_contractility | 0.87563763 |
| 121 | MP0002108_abnormal_muscle_morphology | 0.87538660 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.86732714 |
| 123 | MP0000462_abnormal_digestive_system | 0.86678989 |
| 124 | MP0005310_abnormal_salivary_gland | 0.86610095 |
| 125 | MP0004036_abnormal_muscle_relaxation | 0.85800605 |
| 126 | MP0001270_distended_abdomen | 0.85204383 |
| 127 | MP0008469_abnormal_protein_level | 0.84612002 |
| 128 | MP0002254_reproductive_system_inflammat | 0.83003863 |
| 129 | MP0005330_cardiomyopathy | 0.82470594 |
| 130 | MP0005397_hematopoietic_system_phenotyp | 0.82083296 |
| 131 | MP0001545_abnormal_hematopoietic_system | 0.82083296 |
| 132 | MP0000749_muscle_degeneration | 0.81999650 |
| 133 | MP0008438_abnormal_cutaneous_collagen | 0.81325029 |
| 134 | MP0001542_abnormal_bone_strength | 0.80588084 |
| 135 | MP0005508_abnormal_skeleton_morphology | 0.78965189 |
| 136 | MP0001191_abnormal_skin_condition | 0.77720002 |
| 137 | MP0001299_abnormal_eye_distance/ | 0.77316175 |
| 138 | MP0000613_abnormal_salivary_gland | 0.77226536 |
| 139 | MP0000163_abnormal_cartilage_morphology | 0.76504673 |
| 140 | MP0005367_renal/urinary_system_phenotyp | 0.76265862 |
| 141 | MP0000516_abnormal_urinary_system | 0.76265862 |
| 142 | MP0002139_abnormal_hepatobiliary_system | 0.76063636 |
| 143 | MP0003279_aneurysm | 0.75206366 |
| 144 | MP0000733_abnormal_muscle_development | 0.74817641 |
| 145 | MP0000490_abnormal_crypts_of | 0.74020785 |
| 146 | MP0003690_abnormal_glial_cell | 0.73688959 |
| 147 | MP0000003_abnormal_adipose_tissue | 0.73644305 |
| 148 | MP0001614_abnormal_blood_vessel | 0.73422602 |
| 149 | MP0000920_abnormal_myelination | 0.72373292 |
| 150 | MP0005023_abnormal_wound_healing | 0.72130909 |
| 151 | MP0003566_abnormal_cell_adhesion | 0.71745923 |
| 152 | MP0002168_other_aberrant_phenotype | 0.69955393 |
| 153 | MP0005647_abnormal_sex_gland | 0.69727005 |
| 154 | MP0010030_abnormal_orbit_morphology | 0.68201023 |
| 155 | MP0005375_adipose_tissue_phenotype | 0.62058316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retrobulbar optic neuritis (HP:0100654) | 8.13085970 |
| 2 | Optic neuritis (HP:0100653) | 8.13085970 |
| 3 | Orchitis (HP:0100796) | 7.51890570 |
| 4 | Increased density of long bones (HP:0006392) | 7.27667062 |
| 5 | Myositis (HP:0100614) | 6.84240956 |
| 6 | Persistence of primary teeth (HP:0006335) | 6.40024027 |
| 7 | Keratoconjunctivitis sicca (HP:0001097) | 5.69355369 |
| 8 | Keratoconjunctivitis (HP:0001096) | 5.38468430 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 5.24931016 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.24931016 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.24931016 |
| 12 | Protrusio acetabuli (HP:0003179) | 4.47612746 |
| 13 | Arterial thrombosis (HP:0004420) | 4.40148763 |
| 14 | Premature rupture of membranes (HP:0001788) | 4.37553329 |
| 15 | Pulmonary infiltrates (HP:0002113) | 4.15310270 |
| 16 | IgM deficiency (HP:0002850) | 4.08361122 |
| 17 | Premature loss of primary teeth (HP:0006323) | 3.79219571 |
| 18 | Neurofibrillary tangles (HP:0002185) | 3.28963147 |
| 19 | Nuclear cataract (HP:0100018) | 3.19655239 |
| 20 | Interstitial pulmonary disease (HP:0006530) | 3.10918835 |
| 21 | Hemoptysis (HP:0002105) | 3.08502026 |
| 22 | Osteolytic defects of the hand bones (HP:0009699) | 3.07756894 |
| 23 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.07756894 |
| 24 | Pulmonary artery stenosis (HP:0004415) | 3.06700155 |
| 25 | Vasculitis (HP:0002633) | 3.06225697 |
| 26 | Loss of speech (HP:0002371) | 3.05200659 |
| 27 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.04931593 |
| 28 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.04931593 |
| 29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.04931593 |
| 30 | Keratitis (HP:0000491) | 3.02648242 |
| 31 | Vascular tortuosity (HP:0004948) | 3.01800649 |
| 32 | Dysostosis multiplex (HP:0000943) | 3.01087305 |
| 33 | Rhinitis (HP:0012384) | 2.97172694 |
| 34 | Ankle contracture (HP:0006466) | 2.93898399 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.89336648 |
| 36 | Mucopolysacchariduria (HP:0008155) | 2.89336648 |
| 37 | Arterial tortuosity (HP:0005116) | 2.85036482 |
| 38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.84311259 |
| 39 | Abnormality of the nasal septum (HP:0000419) | 2.82966197 |
| 40 | Axonal loss (HP:0003447) | 2.78579554 |
| 41 | Pulmonary embolism (HP:0002204) | 2.78089815 |
| 42 | Short nail (HP:0001799) | 2.77319061 |
| 43 | Upper limb muscle weakness (HP:0003484) | 2.77216217 |
| 44 | Encephalitis (HP:0002383) | 2.70517167 |
| 45 | Wormian bones (HP:0002645) | 2.69632404 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.67218586 |
| 47 | Autoimmune hemolytic anemia (HP:0001890) | 2.65096447 |
| 48 | IgA deficiency (HP:0002720) | 2.63323367 |
| 49 | Vacuolated lymphocytes (HP:0001922) | 2.61423264 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.60024368 |
| 51 | Gangrene (HP:0100758) | 2.59817119 |
| 52 | Increased CSF protein (HP:0002922) | 2.55678365 |
| 53 | Myocardial infarction (HP:0001658) | 2.54251426 |
| 54 | Distal lower limb muscle weakness (HP:0009053) | 2.48081960 |
| 55 | Thyroiditis (HP:0100646) | 2.47872773 |
| 56 | Glomerulopathy (HP:0100820) | 2.45904533 |
| 57 | Stomatitis (HP:0010280) | 2.45784664 |
| 58 | Broad metatarsal (HP:0001783) | 2.45191129 |
| 59 | Cranial hyperostosis (HP:0004437) | 2.45083371 |
| 60 | Alopecia of scalp (HP:0002293) | 2.43246116 |
| 61 | Cerebral aneurysm (HP:0004944) | 2.42829028 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.41306446 |
| 63 | Anorexia (HP:0002039) | 2.39509144 |
| 64 | Bladder diverticulum (HP:0000015) | 2.36967503 |
| 65 | Mutism (HP:0002300) | 2.36400206 |
| 66 | Abnormal albumin level (HP:0012116) | 2.33590050 |
| 67 | Hypoalbuminemia (HP:0003073) | 2.33590050 |
| 68 | Gastrointestinal stroma tumor (HP:0100723) | 2.32264184 |
| 69 | Asymmetric septal hypertrophy (HP:0001670) | 2.32074341 |
| 70 | Joint stiffness (HP:0001387) | 2.30518754 |
| 71 | Meningitis (HP:0001287) | 2.30353712 |
| 72 | Osteomyelitis (HP:0002754) | 2.29211577 |
| 73 | Symptomatic seizures (HP:0011145) | 2.27226319 |
| 74 | Spastic diplegia (HP:0001264) | 2.25220576 |
| 75 | Soft skin (HP:0000977) | 2.24276894 |
| 76 | Aortic regurgitation (HP:0001659) | 2.23981518 |
| 77 | Increased cerebral lipofuscin (HP:0011813) | 2.21588615 |
| 78 | Adactyly (HP:0009776) | 2.19774781 |
| 79 | Recurrent bronchitis (HP:0002837) | 2.19580261 |
| 80 | Increased connective tissue (HP:0009025) | 2.18212104 |
| 81 | Follicular hyperkeratosis (HP:0007502) | 2.17260963 |
| 82 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.16048706 |
| 83 | Abnormality of complement system (HP:0005339) | 2.15467428 |
| 84 | Aneurysm (HP:0002617) | 2.12994653 |
| 85 | Thoracolumbar scoliosis (HP:0002944) | 2.12166530 |
| 86 | Abnormality of the pericardium (HP:0001697) | 2.11924568 |
| 87 | Abnormality of primary teeth (HP:0006481) | 2.11643817 |
| 88 | Ulnar claw (HP:0001178) | 2.10648579 |
| 89 | Joint swelling (HP:0001386) | 2.10628626 |
| 90 | Natal tooth (HP:0000695) | 2.10211703 |
| 91 | Aortic valve stenosis (HP:0001650) | 2.09635797 |
| 92 | Dilatation of the ascending aorta (HP:0005111) | 2.09467253 |
| 93 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.07674604 |
| 94 | Recurrent fungal infections (HP:0002841) | 2.06971845 |
| 95 | Atrophic scars (HP:0001075) | 2.06433337 |
| 96 | Pancreatitis (HP:0001733) | 2.05555376 |
| 97 | Thrombophlebitis (HP:0004418) | 2.04217762 |
| 98 | Shallow orbits (HP:0000586) | 2.03695787 |
| 99 | Cerebral inclusion bodies (HP:0100314) | 2.03528175 |
| 100 | Abnormality of eosinophils (HP:0001879) | 2.02918838 |
| 101 | Bradycardia (HP:0001662) | 2.01306216 |
| 102 | Xerostomia (HP:0000217) | 2.00883802 |
| 103 | Complement deficiency (HP:0004431) | 2.00638868 |
| 104 | Depressed nasal tip (HP:0000437) | 1.99225177 |
| 105 | Vertigo (HP:0002321) | 1.98823209 |
| 106 | Abnormality of the pleura (HP:0002103) | 1.98712724 |
| 107 | Irregular vertebral endplates (HP:0003301) | 1.98707101 |
| 108 | Esophageal varix (HP:0002040) | 1.96884019 |
| 109 | Metaphyseal dysplasia (HP:0100255) | 1.93704118 |
| 110 | Abnormality of the endocardium (HP:0004306) | 1.92992396 |
| 111 | Arthralgia (HP:0002829) | 1.92335362 |
| 112 | Hypoplasia of the odontoid process (HP:0003311) | 1.91898085 |
| 113 | Bone cyst (HP:0012062) | 1.91035232 |
| 114 | Abnormality of T cell number (HP:0011839) | 1.90853057 |
| 115 | Ovoid vertebral bodies (HP:0003300) | 1.89918307 |
| 116 | T lymphocytopenia (HP:0005403) | 1.88964855 |
| 117 | Hematochezia (HP:0002573) | 1.86458764 |
| 118 | Cardiovascular calcification (HP:0011915) | 1.85464817 |
| 119 | Hyperglycemia (HP:0003074) | 1.85177029 |
| 120 | Beaking of vertebral bodies (HP:0004568) | 1.84870403 |
| 121 | Aortic dissection (HP:0002647) | 1.84768276 |
| 122 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.84693161 |
| 123 | Acne (HP:0001061) | 1.84542522 |
| 124 | Glucose intolerance (HP:0000833) | 1.83002054 |
| 125 | Type 1 muscle fiber predominance (HP:0003803) | 1.82741311 |
| 126 | Aortic aneurysm (HP:0004942) | 1.81627483 |
| 127 | Hypokinesia (HP:0002375) | 1.80355664 |
| 128 | Thick nail (HP:0001805) | 1.80224645 |
| 129 | Biconcave vertebral bodies (HP:0004586) | 1.79515851 |
| 130 | Inflammation of the large intestine (HP:0002037) | 1.79500323 |
| 131 | Spinal rigidity (HP:0003306) | 1.78806593 |
| 132 | Glomerulonephritis (HP:0000099) | 1.78717533 |
| 133 | Colitis (HP:0002583) | 1.77837527 |
| 134 | Severe combined immunodeficiency (HP:0004430) | 1.77560322 |
| 135 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.77552173 |
| 136 | Absent hand (HP:0004050) | 1.77441980 |
| 137 | Vertebral compression fractures (HP:0002953) | 1.77150698 |
| 138 | Malnutrition (HP:0004395) | 1.76917010 |
| 139 | Polyneuropathy (HP:0001271) | 1.75645504 |
| 140 | Increased IgE level (HP:0003212) | 1.75490601 |
| 141 | Abnormality of the odontoid process (HP:0003310) | 1.74425285 |
| 142 | Mitral stenosis (HP:0001718) | 1.74273122 |
| 143 | Slender build (HP:0001533) | 1.74218619 |
| 144 | Abnormality of T cells (HP:0002843) | 1.73811296 |
| 145 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.73746325 |
| 146 | J-shaped sella turcica (HP:0002680) | 1.73502865 |
| 147 | Distal lower limb amyotrophy (HP:0008944) | 1.73486009 |
| 148 | Amyloidosis (HP:0011034) | 1.73125620 |
| 149 | Elbow flexion contracture (HP:0002987) | 1.72449124 |
| 150 | Mitral regurgitation (HP:0001653) | 1.71688903 |
| 151 | Spontaneous hematomas (HP:0007420) | 1.71587550 |
| 152 | Gingival overgrowth (HP:0000212) | 1.71402228 |
| 153 | Stomach cancer (HP:0012126) | 1.71121901 |
| 154 | Growth hormone excess (HP:0000845) | 1.71085084 |
| 155 | Hoarse voice (HP:0001609) | 1.70325886 |
| 156 | Choroideremia (HP:0001139) | 1.70103108 |
| 157 | Long toe (HP:0010511) | 1.70070666 |
| 158 | Neonatal short-limb short stature (HP:0008921) | 1.69828997 |
| 159 | Portal hypertension (HP:0001409) | 1.68869638 |
| 160 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.68589579 |
| 161 | Hypoplasia of the iris (HP:0007676) | 1.68052424 |
| 162 | Mediastinal lymphadenopathy (HP:0100721) | 1.68036039 |
| 163 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.67988228 |
| 164 | Cervical subluxation (HP:0003308) | 1.67623585 |
| 165 | Pulmonary hypertension (HP:0002092) | 1.67540612 |
| 166 | Skin nodule (HP:0200036) | 1.67164209 |
| 167 | Abnormality of the sella turcica (HP:0002679) | 1.66789710 |
| 168 | Gastrointestinal inflammation (HP:0004386) | 1.66524565 |
| 169 | Abnormality of the fingertips (HP:0001211) | 1.66210513 |
| 170 | Cerebral ischemia (HP:0002637) | 1.66113233 |
| 171 | Alveolar cell carcinoma (HP:0006519) | 1.65548348 |
| 172 | Cellulitis (HP:0100658) | 1.65540142 |
| 173 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.64883874 |
| 174 | Hydroxyprolinuria (HP:0003080) | 1.64559609 |
| 175 | Abnormality of proline metabolism (HP:0010907) | 1.64559609 |
| 176 | Tetraparesis (HP:0002273) | 1.63896573 |
| 177 | Abnormality of the nasal mucosa (HP:0000433) | 1.62444760 |
| 178 | Bone pain (HP:0002653) | 1.62303699 |
| 179 | Hypophosphatemia (HP:0002148) | 1.62105438 |
| 180 | Rectal prolapse (HP:0002035) | 1.62063546 |
| 181 | B lymphocytopenia (HP:0010976) | 1.61493127 |
| 182 | Abnormality of B cell number (HP:0010975) | 1.61493127 |
| 183 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.61480192 |
| 184 | Spondylolisthesis (HP:0003302) | 1.61301780 |
| 185 | Hepatosplenomegaly (HP:0001433) | 1.60828955 |
| 186 | Thin bony cortex (HP:0002753) | 1.60444411 |
| 187 | Striae distensae (HP:0001065) | 1.56332577 |
| 188 | Paresthesia (HP:0003401) | 1.55237390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 6.35109668 |
| 2 | MAPK15 | 4.66277767 |
| 3 | TAOK3 | 4.52037948 |
| 4 | TXK | 4.17113008 |
| 5 | EPHA2 | 3.42434947 |
| 6 | MYLK | 3.30389346 |
| 7 | TSSK6 | 3.13645472 |
| 8 | MAP3K14 | 3.12629717 |
| 9 | DDR2 | 2.88334838 |
| 10 | INSRR | 2.53042061 |
| 11 | STK38L | 2.44335894 |
| 12 | MST1R | 2.37728073 |
| 13 | ITK | 2.34799162 |
| 14 | TBK1 | 2.27977414 |
| 15 | MAP4K1 | 2.09132658 |
| 16 | ABL2 | 2.04681977 |
| 17 | LATS2 | 2.02603405 |
| 18 | PDGFRA | 2.01528522 |
| 19 | AKT3 | 1.96825021 |
| 20 | MAPKAPK5 | 1.93132551 |
| 21 | IKBKB | 1.91934604 |
| 22 | TEC | 1.91833770 |
| 23 | TESK1 | 1.91566243 |
| 24 | LMTK2 | 1.89540766 |
| 25 | JAK1 | 1.86680641 |
| 26 | MET | 1.82189744 |
| 27 | IKBKE | 1.78843033 |
| 28 | PTK2 | 1.76326379 |
| 29 | FER | 1.75796002 |
| 30 | LIMK1 | 1.75521032 |
| 31 | TAOK2 | 1.74149950 |
| 32 | CHUK | 1.66466798 |
| 33 | NUAK1 | 1.65525748 |
| 34 | EPHA3 | 1.61365556 |
| 35 | ERBB4 | 1.58255300 |
| 36 | PDK2 | 1.57896202 |
| 37 | MOS | 1.57487616 |
| 38 | PIM1 | 1.54751233 |
| 39 | PAK2 | 1.52644668 |
| 40 | EPHB1 | 1.50743832 |
| 41 | GRK7 | 1.50524568 |
| 42 | TTN | 1.50080373 |
| 43 | NLK | 1.49307563 |
| 44 | TGFBR2 | 1.48083893 |
| 45 | BTK | 1.44436017 |
| 46 | IRAK2 | 1.43312377 |
| 47 | NEK6 | 1.30577305 |
| 48 | JAK3 | 1.27536068 |
| 49 | NME2 | 1.25867662 |
| 50 | ZAP70 | 1.15935315 |
| 51 | STK24 | 1.14996330 |
| 52 | NEK9 | 1.11970135 |
| 53 | PIM2 | 1.10023323 |
| 54 | KIT | 1.08338830 |
| 55 | STK38 | 1.07347191 |
| 56 | EIF2AK3 | 1.04949820 |
| 57 | IRAK1 | 1.02979855 |
| 58 | CDC42BPA | 1.02681413 |
| 59 | MAP2K2 | 1.01399493 |
| 60 | EPHB2 | 1.00407702 |
| 61 | FGFR3 | 1.00124739 |
| 62 | ERN1 | 0.98945361 |
| 63 | EEF2K | 0.98830846 |
| 64 | GSK3A | 0.98484904 |
| 65 | IRAK4 | 0.97778783 |
| 66 | BCR | 0.96688581 |
| 67 | MAPK7 | 0.94935236 |
| 68 | PAK4 | 0.94628493 |
| 69 | BCKDK | 0.93978193 |
| 70 | CDK3 | 0.92909598 |
| 71 | MAP3K3 | 0.90528306 |
| 72 | ROCK1 | 0.87466879 |
| 73 | MAP3K12 | 0.84722147 |
| 74 | HIPK2 | 0.84462494 |
| 75 | PRKCE | 0.83679134 |
| 76 | VRK1 | 0.83428564 |
| 77 | STK10 | 0.82073323 |
| 78 | ERBB3 | 0.81093329 |
| 79 | MAP2K3 | 0.80359234 |
| 80 | TIE1 | 0.80196610 |
| 81 | PTK2B | 0.80154157 |
| 82 | SYK | 0.79302282 |
| 83 | FGFR4 | 0.77820950 |
| 84 | TGFBR1 | 0.77642955 |
| 85 | MAP3K6 | 0.75711590 |
| 86 | HCK | 0.70919206 |
| 87 | CDK8 | 0.69349258 |
| 88 | SIK1 | 0.67679571 |
| 89 | TRPM7 | 0.67462345 |
| 90 | PTK6 | 0.63961298 |
| 91 | PAK3 | 0.63741395 |
| 92 | LATS1 | 0.63605862 |
| 93 | LCK | 0.63306794 |
| 94 | CDK12 | 0.62331580 |
| 95 | CAMK2D | 0.61752532 |
| 96 | BMX | 0.61558748 |
| 97 | CAMK2G | 0.61416063 |
| 98 | RPS6KA4 | 0.60673215 |
| 99 | FGFR1 | 0.59577240 |
| 100 | NTRK1 | 0.58957602 |
| 101 | ADRBK2 | 0.58482252 |
| 102 | MATK | 0.58382673 |
| 103 | MAPK12 | 0.58342341 |
| 104 | TYK2 | 0.58240487 |
| 105 | GRK6 | 0.58058082 |
| 106 | PASK | 0.57322141 |
| 107 | ARAF | 0.56382635 |
| 108 | MAP3K11 | 0.56375146 |
| 109 | MAP3K1 | 0.54023516 |
| 110 | MAPKAPK2 | 0.51170877 |
| 111 | DAPK3 | 0.49992168 |
| 112 | ROCK2 | 0.48079250 |
| 113 | PRKD1 | 0.48076555 |
| 114 | RPS6KA2 | 0.47764440 |
| 115 | PDGFRB | 0.45660885 |
| 116 | ADRBK1 | 0.45214279 |
| 117 | TAOK1 | 0.44530956 |
| 118 | FRK | 0.43947040 |
| 119 | IGF1R | 0.43901579 |
| 120 | CLK1 | 0.43643608 |
| 121 | MARK3 | 0.43546539 |
| 122 | BMPR1B | 0.43212598 |
| 123 | LYN | 0.42559940 |
| 124 | PAK1 | 0.42545590 |
| 125 | DYRK1B | 0.41924026 |
| 126 | RPS6KB1 | 0.41018298 |
| 127 | DMPK | 0.39679479 |
| 128 | JAK2 | 0.39455303 |
| 129 | GRK1 | 0.38960891 |
| 130 | MUSK | 0.38956319 |
| 131 | RPS6KA5 | 0.37835552 |
| 132 | CSNK1A1L | 0.37261085 |
| 133 | MELK | 0.36853448 |
| 134 | BMPR2 | 0.36726783 |
| 135 | MTOR | 0.36600958 |
| 136 | MAPKAPK3 | 0.36199831 |
| 137 | RIPK1 | 0.35012806 |
| 138 | MKNK2 | 0.34775201 |
| 139 | RPS6KA1 | 0.33880320 |
| 140 | CDK9 | 0.33845122 |
| 141 | MST4 | 0.33721588 |
| 142 | BRD4 | 0.32906915 |
| 143 | PRKCI | 0.32407460 |
| 144 | CDK6 | 0.31416869 |
| 145 | TNK2 | 0.31361019 |
| 146 | MAPK3 | 0.31348714 |
| 147 | PRKG2 | 0.30917187 |
| 148 | PRKCQ | 0.30689611 |
| 149 | MAPK4 | 0.28862721 |
| 150 | RPS6KB2 | 0.28590031 |
| 151 | SIK3 | 0.28345672 |
| 152 | INSR | 0.27884101 |
| 153 | ABL1 | 0.27735274 |
| 154 | FES | 0.27480686 |
| 155 | MAP3K7 | 0.26789151 |
| 156 | CSK | 0.26488716 |
| 157 | MAP3K2 | 0.25719255 |
| 158 | PRKCH | 0.24641887 |
| 159 | MAPK1 | 0.24570108 |
| 160 | STK3 | 0.22855686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 4.56262560 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.05614994 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.97210288 |
| 4 | Circadian rhythm_Homo sapiens_hsa04710 | 2.77519971 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.71131023 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.67954413 |
| 7 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.48486361 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.39265949 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.37687821 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.20453976 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.17809069 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.15093380 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.96584814 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.94516411 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.92516967 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91942031 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.91016608 |
| 18 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.89031204 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.81705491 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79107178 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72869319 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66500871 |
| 23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.64384615 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.63304849 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.63262762 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63083869 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.61654703 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.61356064 |
| 29 | Mineral absorption_Homo sapiens_hsa04978 | 1.59939702 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.58327772 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.54722792 |
| 32 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.51931291 |
| 33 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.51476987 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.34441814 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.33375497 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.28805255 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28008991 |
| 38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.26371892 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.24849469 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.24784650 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.23512575 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16491605 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.13088679 |
| 44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09762133 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08227367 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05439563 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04373458 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.03668091 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03251552 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03048545 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03009291 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 1.01858891 |
| 53 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.01698794 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01215517 |
| 55 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.01043442 |
| 56 | Protein export_Homo sapiens_hsa03060 | 0.98864770 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96264341 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95935217 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.95929214 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.94435383 |
| 61 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92107957 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.92012401 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91243283 |
| 64 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.90142920 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.89541620 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.89227754 |
| 67 | Bladder cancer_Homo sapiens_hsa05219 | 0.88629560 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.88454848 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88338563 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88120174 |
| 71 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.86069823 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.83052231 |
| 73 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81403943 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.80658491 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79477334 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75136384 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.73567806 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73404356 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.72496527 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71680892 |
| 81 | Prostate cancer_Homo sapiens_hsa05215 | 0.71392646 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70500073 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.69708390 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69685274 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.69245726 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68649642 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.67665028 |
| 88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67294692 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.67104801 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65911640 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.65786923 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65387155 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63796028 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.61037129 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60647414 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58717924 |
| 97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58686941 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56849467 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56734235 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55779519 |
| 101 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55528661 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55392856 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54088109 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52615318 |
| 105 | Salivary secretion_Homo sapiens_hsa04970 | 0.51599027 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51518195 |
| 107 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.50627733 |
| 108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50549271 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50338505 |
| 110 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49982835 |
| 111 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48964661 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48023167 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.47192661 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45185450 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44993515 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.44337776 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43551538 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42195441 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40655365 |
| 120 | Insulin secretion_Homo sapiens_hsa04911 | 0.40089887 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39530688 |
| 122 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39206467 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38601892 |
| 124 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.38261136 |
| 125 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37376511 |
| 126 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.37116294 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36876619 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.36197913 |
| 129 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.35795024 |
| 130 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35089502 |
| 131 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34898686 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34663251 |
| 133 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32679409 |
| 134 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32224324 |
| 135 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.31094059 |

